Skip to content

Innovative research on whole course management and precise prevention and treatment system of atopic dermatitis in children

Innovative research on whole course management and precise prevention and treatment system of atopic dermatitis in children

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300076217
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

High disease activity group:None

Sponsors

Chongqing Medical University Affiliated Children's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: (1) Age: March to 18 years old; (2) Atopic dermatitis diagnosed according to Williams criteria or modified Williams criteria: with a history of skin itching for at least 1 month, plus 3 or more of the following: a. a history of skin involvement on the flexor side, including the cubital fossa, knee fossa, anterior ankle, or neck; b. A personal history of asthma or allergic rhinitis, or a history of atopic dermatitis in children under the age of 4 in first degree relatives; c. A history of dry skin throughout the body; d. Eczema can be seen on the flexed side or on the cheeks, forehead, and distal limbs of children under 4 years old; e. Disease onset before the age of 2 (not applicable to children under 4 years old); (3) The guardian has signed an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with severe heart, lung, liver, kidney and other organ and systemic diseases; (2) Those who have recently used systemic immunosuppressive therapy (such as glucocorticoids); (3) Other diseases characterized by atopic dermatitis and skin lesions; (4) Individuals with systemic symptoms; (5) According to the researcher's judgment, guardians are unreliable or have poor compliance.

Design outcomes

Primary

MeasureTime frame
Eczema area and severity index,EASI;Dermatology life quality index(DLQI) score;patient-oriented eczema measure,POEM;Atopic dermatitis control test,ADCT;pp-NRS;

Countries

China

Contacts

Public ContactLuo Xiaoyan

Chongqing Medical University Affiliated Children's Hospital

xyluo@hospital.cqmu.edu.cn+86 130 1238 1671

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026